Disagregin

N/A

Report date: 2023/02/18 19:47:07

Base Information

Drug NameDisagregin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFibrinogen receptors inhibitorsIntegrin alpha-IIb/beta-3 antagonistsPlatelet aggregation inhibitors
TargetsIntegrin alpha-IIb/beta-3Fibrinogen receptors
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A